Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Chembio, CombiMatrix

Premium

Chembio this week named Michael Steele vice president of sales, marketing, and business development.

Steele was previously employed by Chembio as a consultant. Before that he was vice president of business development at Seracare Life Sciences as well as director and managing director at Serologicals before it was acquired by Millipore.


CombiMatrix has named Mark McDonough its new chief commercial officer.

McDonough was previously vice president of sales, customer service, and training at Pathwork Diagnostics and he spent six years at USLabs/Dianon, where he eventually became vice president of sales.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.